Related Experiment Video

Updated: Mar 23, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Alcoholic liver disease and the hepatitis C virus: an overview and a point of view

Gianni Testino1, Silvia Leone, Paolo Borro

  • 1Alcohologic Regional Centre, Liguria Region, IRCCS AOU San Martino-IST (National Institute for Research on Cancer), Genoa, Italy - gianni.testino@hsanmartino.it.

Minerva Medica
|March 26, 2016
PubMed

Insights

Alcoholic liver disease (ALD) and hepatitis C virus (HCV) co-infection accelerates liver cirrhosis and cancer. Eradicating HCV infection is crucial for patient motivation and improved outcomes.

Area of Science:

  • Hepatology
  • Viral Hepatitis
  • Alcohol-Related Liver Disease

Background:

  • Alcoholic liver disease (ALD) and hepatitis C virus (HCV) infections frequently coexist.
  • Co-infection significantly increases the risk of liver cirrhosis and hepatocellular carcinoma (HCC).
  • Synergistic effects on oxidative stress, immune response, and carcinogenesis drive disease progression.

Purpose of the Study:

  • To highlight the accelerated progression of liver disease in patients with co-existing ALD and HCV.
  • To discuss the clinical implications of acute-on-chronic liver failure (ACLF) in this population.
  • To review current and emerging treatment strategies, emphasizing the role of antiviral therapy and alcohol abstinence.

Main Methods:

  • Review of existing literature on ALD and HCV co-infection.
  • Analysis of disease progression markers and risk factors.
  • Evaluation of treatment outcomes for antiviral therapies and liver transplantation.

Main Results:

  • Co-infection with ALD and HCV markedly elevates the risk of liver cirrhosis and HCC.
  • Acute-on-chronic liver failure (ACLF) presents a severe clinical challenge in advanced HCV with superimposed alcoholic hepatitis.
  • Antiviral therapy (PEG-IFN and Ribavirin) shows efficacy, with eradication motivating alcohol abstinence.

Conclusions:

  • HCV eradication is a key motivator for alcohol abstinence in co-infected patients.
  • Regular ultrasonographic surveillance is essential for monitoring HCC risk, even post-eradication.
  • Continued research into new antiviral drugs is necessary to manage this complex co-morbidity.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

20.0K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
29
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
860
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
11